When access challenges stall treatment, the right audience (not broader reach) makes all the difference. In this case study, discover how an oncology brand partnered with Skipta to leverage the real‑world data foundation of NorstellaLinQ, enabling precise identification of the specialty pharmacists who influence access and treatment decisions. That precision targeting translated directly into measurable performance.
Discover how real-world data was used to pinpoint specialty PharmDs co-located with or sharing patients with target HCPs.
Learn how targeted banners, sponsored content, and triggered emails outperformed standard outreach.
Explore the engagement metrics that delivered 3X higher click performance versus non-triggered campaigns.
Understand how this approach can be replicated to support access strategies across brands and therapy areas.